Methods of use of dual PPAR agonist compounds and drug delivery devices containing such compounds

Details for Australian Patent Application No. 2006206682 (hide)

Owner Novartis AG

Inventors Cohen, David Saul

Agent Davies Collison Cave

Pub. Number AU-A-2006206682

PCT Pub. Number WO2006/078605

Priority 60/644,646 18.01.05 US

Filing date 17 January 2006

Wipo publication date 27 July 2006

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61L 31/16 (2006.01) Materials for other surgical articles

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/078605 Priority application(s): WO2006/078605

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006206687-Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis or treatment of progressive multifocal leukoencephalopathy

2006206679-Omnidirectional tilt and vibration sensor